Actividad neutralizadora de anticuerpos contra el SARS-CoV-2 VOC B.1.617.2 y B.1.351 mediante la vacunación BNT162b2
Video Experimental Relacionado
Updated: Nov 3, 2025
06:08
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.4K
Emma C Wall1, Mary Wu2, Ruth Harvey2
1Francis Crick Institute, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
Lancet (London, England)
|June 6, 2021
Resumen
No abstract available in PubMed .
